14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -5.133 25 days ( 29.66 % )
Last Price $3.70 4.82 %
High/ Low $3.47 - $3.70 15.27%
Chg 7 Days 16.17 % $3.19 $3.70
Chg 30 Days -14.55 % $4.33 $3.70
Chg 12 mos -16.10 % $4.41 $3.70
Trend - 3 mos -25.54 % Width: 235.11 %
Trend - 12 mos -14.98 % Width: 1,157.06 %
Pred. range - 3 mos $1.45 - $4.86 -60.78 % - 31.44 %
Pred. range - 12 mos $0.554 - $6.97 -85.02 % - 88.36 %
Short MA avg 3 mos Buy Apr 26, 2024 - 5 days
Long MA avg 3 mos Sell Mar 27, 2024 - 26 days
Short/Long MA avg 3 mos Sell Apr 02, 2024 - 23 days
Short MA avg 12 mos Sell Mar 27, 2024 - 26 days
Long MA avg 12 mos Sell Apr 12, 2024 - 15 days
Short/Long MA avg 12 mos Sell Apr 24, 2024 - 7 days
Pivot Short Sell Mar 27, 2024 - 26 days
Bollinger Buy Mar 26, 2024 - 27 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Kodiak Sciences Inc.

Kodiak Sciences. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, ... KOD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT